Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Trading Statement

28 Jan 2021 07:00

RNS Number : 1277N
De La Rue PLC
28 January 2021
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the (Retained EU Legislation) Market Abuse Regulation (EU) No.596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

28 January 2021

DE LA RUE PLC

TRADING UPDATE

De La Rue plc (LSE: DLAR) ("De La Rue" or the "Company") today announces a trading update for financial year 2020/21 starting 29 March 2020, and developments in its polymer banknote strategy.

 

The Company has seen positive trading in this financial year, with good progress on the implementation of its Turnaround Plan. As a result, the Board's expectations for adjusted operating profit for the financial year 2020/21 are in the range of £36 million to £37 million, compared with current market expectations of approximately £34 million.(1)

The Board is confident of these expectations, absent any significant unforeseen COVID-19 related event. The Company remains diligent on its COVID-19 safety measures and has year-to-date effectively mitigated the challenges of the pandemic.

The improved expectations are largely driven by a strong Currency division performance. De La Rue recognises that the pandemic is causing some delays in securing new government revenue solutions contracts with overseas governments by its Authentication division, due to disruption in procurement processes.

De La Rue also announces that it has decided on a UK location for the expansion of manufacturing capacity for its SAFEGUARD® polymer substrate. The additional production line will be located in a recently acquired building adjacent to its existing premises in Westhoughton, near Bolton, creating operational efficiencies. The Company expects the new line to be fully operational before the end of calendar year 2021 and that it will more than double current polymer production capacity. De La Rue plans to recruit up to an additional 70 people during the next two and a half years as part of this investment.

As a result of the continued positive momentum of customers switching to De La Rue's SAFEGUARD® polymer substrate, and to create more possibilities in relation to future expansion, the Company now plans to spend approximately £20 million on its polymer strategy, an increase on the approximately £15 million previously indicated. Total aggregate 3-year investment for the Turnaround Plan remains unchanged at £79.8 million.

Clive Vacher, CEO of De La Rue, said, "I am pleased that we are able to report increased adjusted operating profit expectations for the year, due to positive trading. We remain focused on delivering shareholder value through the successful execution of our Turnaround Plan.

"In addition, I am delighted to announce further investment in manufacturing and job creation in the North West of the UK, as we continue to increase our polymer market share globally. The Currency team has done a remarkable job in bringing De La Rue's SAFEGUARD® polymer substrate to a position of industry leadership.

"It is a fitting endorsement of the technical and operational capabilities of our Westhoughton site, that we have made the decision to concentrate our polymer substrate manufacturing into this Centre of Excellence."

De La Rue expects to announce its results for the full year ended 27 March 2021 on 26 May 2021.

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

(1). Market expectations are based on the average of published notes from Investec and Numis Securities.

Enquiries:

 

De La Rue plc

 

+44 (0) 7387 122645

Clive Vacher

 

Chief Executive Officer

Rob Harding

 

Chief Financial Officer

Matthew Rose

 

Director of Tax, Treasury and Investor Relations

 

Brunswick Group LLP +44 (0)207 404 5959

Stuart Donnelly/ Imran Jina

 

 

Cautionary note regarding forward-looking statements

 

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "plans", "may", "will", "could", "shall", "risk", "aims", "predicts", "continues", "assumes", "positioned" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the directors, De La Rue or the Group concerning, amongst other things, the results of operations, financial condition, liquidity, prospects, growth and strategies of De La Rue and the industry in which it operates.

By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of the Company. Past performance cannot be relied upon as a guide to future performance and should not be taken as a representation or assurance that trends or activities underlying past performance will continue in the future. Accordingly, investors or potential investors should not place undue reliance on these forward-looking statements. The Group's actual results of operations, financial condition, liquidity and the development of the industry in which it operates may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the results of operations, financial condition and liquidity of the Group and the development of the industry in which it operates, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

Other than in accordance with its legal or regulatory obligations, De La Rue does not undertake any obligation to update these forward-looking statements, which speak only as at the date of this announcement, and will not publicly release any revisions that may be made to these forward-looking statements, which may result from events or circumstances arising after the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRMLTMTBTBJB
Date   Source Headline
8th Jul 20212:43 pmRNSDirector/PDMR Shareholding
6th Jul 20212:51 pmRNSDirector/PDMR Shareholding
1st Jul 20214:35 pmRNSBlock listing Interim Review
1st Jul 20214:21 pmRNSTotal Voting Rights
1st Jul 20218:00 amRNSDirector/PDMR Shareholding
28th Jun 20213:55 pmRNSHolding(s) in Company
24th Jun 202111:24 amRNSHolding(s) in Company
18th Jun 20211:44 pmRNSAnnual Financial Report
1st Jun 202111:23 amRNSTotal Voting Rights
26th May 20217:00 amRNS2020/21 Full Year Results
13th May 20217:00 amRNSAUTHENTICATION CONTRACT WINS
4th May 20212:07 pmRNSTotal Voting Rights
13th Apr 20217:00 amRNSTrading Statement
1st Apr 20217:00 amRNSTotal Voting Rights
23rd Mar 20215:09 pmRNSHolding(s) in Company
23rd Mar 20217:00 amRNSDirectorate Change
1st Mar 202112:20 pmRNSTotal Voting Rights
1st Feb 202112:37 pmRNSTotal Voting Rights
28th Jan 202112:59 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSTrading Statement
5th Jan 20219:36 amRNSDirector/PDMR Shareholding
4th Jan 202111:15 amRNSBlock listing Interim Review
4th Jan 202111:12 amRNSTotal Voting Rights
23rd Dec 202012:10 pmRNSDirector/PDMR Shareholding
1st Dec 20202:25 pmRNSTotal Voting Rights
1st Dec 20209:10 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNS2020/21 HALF YEAR RESULTS
4th Nov 20201:45 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSEXTENSION OF THE BANK OF ENGLAND CONTRACT
21st Oct 202011:32 amRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
1st Oct 20201:30 pmRNSTotal Voting Rights
1st Oct 20207:00 amRNSChief Financial Officer Appointment
22nd Sep 20207:00 amRNSDirectorate Change
1st Sep 202012:14 pmRNSTotal Voting Rights
24th Aug 20203:05 pmRNSHolding(s) in Company
13th Aug 20207:00 amRNSAppointment of Joint Broker
7th Aug 20204:42 pmRNSHolding(s) in Company
6th Aug 202012:40 pmRNSResult of AGM
6th Aug 20207:00 amRNSAGM Statement
4th Aug 20209:37 amRNSHolding(s) in Company
31st Jul 20203:52 pmRNSTotal Voting Rights
27th Jul 20207:00 amRNSAdditional Listing
22nd Jul 20206:00 pmRNSHolding(s) in Company
16th Jul 20205:12 pmRNSDirector/PDMR Shareholding
15th Jul 20204:13 pmRNSHolding(s) in Company
14th Jul 20203:03 pmRNSHolding(s) in Company
14th Jul 20202:40 pmRNSHolding(s) in Company
13th Jul 20203:18 pmRNSNotice of AGM
13th Jul 20203:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.